Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2012

Segment Reporting (Tables) [Abstract]

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows:

	Year Ended December 31,
(in millions)	2012		2011		2010
Net sales	(restated)		(restated)		(restated)
Interventional Cardiology	$	2,179	$	2,444	$	2,624
Peripheral Interventions	769		713		677
Cardiovascular	2,948		3,157		3,301
Cardiac Rhythm Management	1,927		2,072		2,216
Electrophysiology	147		145		147
Rhythm Management	2,074		2,217		2,363
Endoscopy	1,242		1,158		1,090
Urology/Women's Health	496		491		482
Neuromodulation	367		336		305
MedSurg	2,105		1,985		1,877
Net sales allocated to reportable segments	7,127		7,359		7,541
Sales generated from business divestitures	122		140		346
Impact of foreign currency fluctuations	—		123		(81		)
	$	7,249	$	7,622	$	7,806

Reconciliation of depreciation by reportable segment to total [Table Text Block]

	Year Ended December 31,
(in millions)	2012		2011		2010
Depreciation expense	(restated)		(restated)		(restated)
Cardiovascular	$	106	$	116	$	118
Rhythm Management	108		105		107
MedSurg	74		73		78
Depreciation expense allocated to reportable segments	288		294		303
Impact of foreign currency fluctuations	—		2		—
	$	288	$	296	$	303

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2012			2011			2010
Income (loss) before income taxes	(restated)			(restated)			(restated)
Cardiovascular	$	739		$	829		$	872
Rhythm Management	242			320			355
MedSurg	637			565			587
Operating income allocated to reportable segments	1,618			1,714			1,814
Corporate expenses and currency exchange	(258		)	(254		)	(253		)
Goodwill and intangible asset impairment charges and acquisition-, divestiture-, litigation-, and restructuring-related net charges	(4,833		)	(135		)	(1,704		)
Amortization expense	(395		)	(421		)	(513		)
Operating income (loss)	(3,868		)	904			(656		)
Other expense, net	(239		)	(262		)	(407		)
	$	(4,107	)	$	642		$	(1,063	)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	As of December 31,
(in millions)	2012		2011
Total assets	(restated)		(restated)
Cardiovascular	$	1,535	$	1,660
Rhythm Management	1,350		1,390
MedSurg	967		953
Total assets allocated to reportable segments	3,852		4,003
Goodwill	5,973		9,761
Other intangible assets	6,289		6,473
All other corporate assets	1,040		1,053
	$	17,154	$	21,290

Reconciliation of sales by division and region to consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2012		2011		2010
Net sales
Interventional Cardiology	$	2,179	$	2,495	$	2,602
Cardiac Rhythm Management	1,908		2,087		2,180
Endoscopy	1,252		1,187		1,079
Peripheral Interventions	774		731		669
Urology/Women’s Health	500		498		481
Neuromodulation	367		336		304
Electrophysiology	147		147		147
	7,127		7,481		7,462
Sales generated from divested businesses	122		141		344
	$	7,249	$	7,622	$	7,806
United States	$	3,756	$	4,010	$	4,215
Japan	931		951		886
Other foreign countries	2,440		2,520		2,361
	7,127		7,481		7,462
Sales generated from divested businesses	122		141		344
	$	7,249	$	7,622	$	7,806

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	As of December 31,
(in millions)	2012		2011		2010
Long-lived assets
United States	$	1,065	$	1,141	$	1,188
Ireland	252		231		219
Other foreign countries	247		298		290
Property, plant and equipment, net	1,564		1,670		1,697
Goodwill	5,973		9,761		10,186
Other intangible assets	6,289		6,473		6,343
	$	13,826	$	17,904	$	18,226